Protein tyrosine phosphatase (PTPN)1/2 expression was found to be downregulated in ALK+ ALCL, leading to the overactivation of MEK, SHP2, and Janus kinase (JAK)/STAT and resistance to ALK TKIs (72). The gene discussed is MAP2K7; the disease is anaplastic large cell lymphoma.